Abstract
Summary
Livestock vaccines are substances used to stimulate an immune response in animals, providing them with immunity against specific diseases. Vaccination is a critical component of livestock management as it helps prevent the spread of infectious diseases, reduces economic losses, and ensures the overall health and well-being of the animal population. Various vaccines are developed and administered to livestock, including cattle, sheep, goats, pigs, poultry, and other farm animals.
The global market for Livestock Vaccines was estimated to be worth US$ 4759 million in 2023 and is forecast to a readjusted size of US$ 6156.3 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030
Here are some factors that generally contribute to the growth of the livestock vaccines market:
Prevalence of Livestock Diseases:
The incidence and prevalence of infectious diseases in livestock populations drive the demand for vaccines. As new diseases emerge or existing ones become more widespread, there is an increased need for effective vaccines.
Government Initiatives and Regulations:
Government support, regulatory initiatives, and vaccination programs aimed at controlling and preventing livestock diseases can significantly impact the growth of the market. Regulatory compliance may drive vaccine adoption.
Increasing Livestock Production:
The growth of the livestock vaccines market is often linked to the overall expansion of the livestock industry. As the demand for meat, milk, and other animal products rises, there is a corresponding need for disease prevention to maintain herd health.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Livestock Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Livestock Vaccines by region & country, by Type, and by Application.
The Livestock Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Livestock Vaccines.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Segment by Type:
Foot and Mouth Disease Vaccine
Pig Ring Vaccine
Bird Flu Vaccine
Porcine Blue Ear Vaccine
Swine Fever Vaccine
Segment by Application
Pig
Cattle and Sheep
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Livestock Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Livestock Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Livestock Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Livestock Vaccines was estimated to be worth US$ 4759 million in 2023 and is forecast to a readjusted size of US$ 6156.3 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030
Here are some factors that generally contribute to the growth of the livestock vaccines market:
Prevalence of Livestock Diseases:
The incidence and prevalence of infectious diseases in livestock populations drive the demand for vaccines. As new diseases emerge or existing ones become more widespread, there is an increased need for effective vaccines.
Government Initiatives and Regulations:
Government support, regulatory initiatives, and vaccination programs aimed at controlling and preventing livestock diseases can significantly impact the growth of the market. Regulatory compliance may drive vaccine adoption.
Increasing Livestock Production:
The growth of the livestock vaccines market is often linked to the overall expansion of the livestock industry. As the demand for meat, milk, and other animal products rises, there is a corresponding need for disease prevention to maintain herd health.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Livestock Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Livestock Vaccines by region & country, by Type, and by Application.
The Livestock Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Livestock Vaccines.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Segment by Type:
Foot and Mouth Disease Vaccine
Pig Ring Vaccine
Bird Flu Vaccine
Porcine Blue Ear Vaccine
Swine Fever Vaccine
Segment by Application
Pig
Cattle and Sheep
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Livestock Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Livestock Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Livestock Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Livestock Vaccines Product Introduction
1.2 Global Livestock Vaccines Market Size Forecast
1.2.1 Global Livestock Vaccines Sales Value (2019-2030)
1.2.2 Global Livestock Vaccines Sales Volume (2019-2030)
1.2.3 Global Livestock Vaccines Sales Price (2019-2030)
1.3 Livestock Vaccines Market Trends & Drivers
1.3.1 Livestock Vaccines Industry Trends
1.3.2 Livestock Vaccines Market Drivers & Opportunity
1.3.3 Livestock Vaccines Market Challenges
1.3.4 Livestock Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Livestock Vaccines Players Revenue Ranking (2023)
2.2 Global Livestock Vaccines Revenue by Company (2019-2024)
2.3 Global Livestock Vaccines Players Sales Volume Ranking (2023)
2.4 Global Livestock Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Livestock Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Livestock Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Livestock Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Livestock Vaccines
2.9 Livestock Vaccines Market Competitive Analysis
2.9.1 Livestock Vaccines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Livestock Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Livestock Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Foot and Mouth Disease Vaccine
3.1.2 Pig Ring Vaccine
3.1.3 Bird Flu Vaccine
3.1.4 Porcine Blue Ear Vaccine
3.1.5 Swine Fever Vaccine
3.2 Global Livestock Vaccines Sales Value by Type
3.2.1 Global Livestock Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Livestock Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Livestock Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Livestock Vaccines Sales Volume by Type
3.3.1 Global Livestock Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Livestock Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Livestock Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Livestock Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pig
4.1.2 Cattle and Sheep
4.1.3 Others
4.2 Global Livestock Vaccines Sales Value by Application
4.2.1 Global Livestock Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Livestock Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Livestock Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Livestock Vaccines Sales Volume by Application
4.3.1 Global Livestock Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Livestock Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Livestock Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Livestock Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Livestock Vaccines Sales Value by Region
5.1.1 Global Livestock Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Livestock Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Livestock Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Livestock Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Livestock Vaccines Sales Volume by Region
5.2.1 Global Livestock Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Livestock Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Livestock Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Livestock Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Livestock Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Livestock Vaccines Sales Value, 2019-2030
5.4.2 North America Livestock Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Livestock Vaccines Sales Value, 2019-2030
5.5.2 Europe Livestock Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Livestock Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Livestock Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Livestock Vaccines Sales Value, 2019-2030
5.7.2 South America Livestock Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Livestock Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Livestock Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Livestock Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Livestock Vaccines Sales Value
6.2.1 Key Countries/Regions Livestock Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Livestock Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Livestock Vaccines Sales Value, 2019-2030
6.3.2 United States Livestock Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Livestock Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Livestock Vaccines Sales Value, 2019-2030
6.4.2 Europe Livestock Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Livestock Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Livestock Vaccines Sales Value, 2019-2030
6.5.2 China Livestock Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Livestock Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Livestock Vaccines Sales Value, 2019-2030
6.6.2 Japan Livestock Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Livestock Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Livestock Vaccines Sales Value, 2019-2030
6.7.2 South Korea Livestock Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Livestock Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Livestock Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Livestock Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Livestock Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Livestock Vaccines Sales Value, 2019-2030
6.9.2 India Livestock Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Livestock Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Livestock Vaccines Product Offerings
7.1.5 Merck Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Information
7.2.2 Boehringer Ingelheim Introduction and Business Overview
7.2.3 Boehringer Ingelheim Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Livestock Vaccines Product Offerings
7.2.5 Boehringer Ingelheim Recent Development
7.3 Ceva
7.3.1 Ceva Company Information
7.3.2 Ceva Introduction and Business Overview
7.3.3 Ceva Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Ceva Livestock Vaccines Product Offerings
7.3.5 Ceva Recent Development
7.4 Zoetis
7.4.1 Zoetis Company Information
7.4.2 Zoetis Introduction and Business Overview
7.4.3 Zoetis Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Zoetis Livestock Vaccines Product Offerings
7.4.5 Zoetis Recent Development
7.5 Vaxxinova®
7.5.1 Vaxxinova® Company Information
7.5.2 Vaxxinova® Introduction and Business Overview
7.5.3 Vaxxinova® Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Vaxxinova® Livestock Vaccines Product Offerings
7.5.5 Vaxxinova® Recent Development
7.6 Elanco
7.6.1 Elanco Company Information
7.6.2 Elanco Introduction and Business Overview
7.6.3 Elanco Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Elanco Livestock Vaccines Product Offerings
7.6.5 Elanco Recent Development
7.7 QYH Biotech Co., Ltd
7.7.1 QYH Biotech Co., Ltd Company Information
7.7.2 QYH Biotech Co., Ltd Introduction and Business Overview
7.7.3 QYH Biotech Co., Ltd Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 QYH Biotech Co., Ltd Livestock Vaccines Product Offerings
7.7.5 QYH Biotech Co., Ltd Recent Development
7.8 Pulike
7.8.1 Pulike Company Information
7.8.2 Pulike Introduction and Business Overview
7.8.3 Pulike Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pulike Livestock Vaccines Product Offerings
7.8.5 Pulike Recent Development
7.9 Phibro Animal Health Corporation
7.9.1 Phibro Animal Health Corporation Company Information
7.9.2 Phibro Animal Health Corporation Introduction and Business Overview
7.9.3 Phibro Animal Health Corporation Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Phibro Animal Health Corporation Livestock Vaccines Product Offerings
7.9.5 Phibro Animal Health Corporation Recent Development
7.10 JinYu Biotechnology
7.10.1 JinYu Biotechnology Company Information
7.10.2 JinYu Biotechnology Introduction and Business Overview
7.10.3 JinYu Biotechnology Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 JinYu Biotechnology Livestock Vaccines Product Offerings
7.10.5 JinYu Biotechnology Recent Development
7.11 Harbin Pharmaceutical Group
7.11.1 Harbin Pharmaceutical Group Company Information
7.11.2 Harbin Pharmaceutical Group Introduction and Business Overview
7.11.3 Harbin Pharmaceutical Group Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Harbin Pharmaceutical Group Livestock Vaccines Product Offerings
7.11.5 Harbin Pharmaceutical Group Recent Development
7.12 MEVAC
7.12.1 MEVAC Company Information
7.12.2 MEVAC Introduction and Business Overview
7.12.3 MEVAC Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.12.4 MEVAC Livestock Vaccines Product Offerings
7.12.5 MEVAC Recent Development
7.13 Venky's
7.13.1 Venky's Company Information
7.13.2 Venky's Introduction and Business Overview
7.13.3 Venky's Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Venky's Livestock Vaccines Product Offerings
7.13.5 Venky's Recent Development
7.14 Japfa Comfeed Indonesia
7.14.1 Japfa Comfeed Indonesia Company Information
7.14.2 Japfa Comfeed Indonesia Introduction and Business Overview
7.14.3 Japfa Comfeed Indonesia Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Japfa Comfeed Indonesia Livestock Vaccines Product Offerings
7.14.5 Japfa Comfeed Indonesia Recent Development
7.15 Nisseiken
7.15.1 Nisseiken Company Information
7.15.2 Nisseiken Introduction and Business Overview
7.15.3 Nisseiken Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Nisseiken Livestock Vaccines Product Offerings
7.15.5 Nisseiken Recent Development
7.16 Hile
7.16.1 Hile Company Information
7.16.2 Hile Introduction and Business Overview
7.16.3 Hile Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Hile Livestock Vaccines Product Offerings
7.16.5 Hile Recent Development
7.17 Hester Biosciences
7.17.1 Hester Biosciences Company Information
7.17.2 Hester Biosciences Introduction and Business Overview
7.17.3 Hester Biosciences Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Hester Biosciences Livestock Vaccines Product Offerings
7.17.5 Hester Biosciences Recent Development
8 Industry Chain Analysis
8.1 Livestock Vaccines Industrial Chain
8.2 Livestock Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Livestock Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Livestock Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer